Invention Grant
- Patent Title: Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors
-
Application No.: US17485653Application Date: 2021-09-27
-
Publication No.: US11834467B2Publication Date: 2023-12-05
- Inventor: Jinhwa Lee , Suyeon Jo , Keonseung Lim , A Yeong Park , Gadhe Changdev Gorakshnath , Hwajung Nam , Yeonguk Jeon , Yejin Hwang , Jae Eun Kim , Misoon Kim , Seung Mook Lim
- Applicant: 1ST Biotherapeutics, Inc.
- Applicant Address: KR Gyeonggi-do
- Assignee: 1ST Biotherapeutics, Inc.
- Current Assignee: 1ST Biotherapeutics, Inc.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Harness, Dickey & Pierce, P.L.C.
- Main IPC: A61K31/416
- IPC: A61K31/416 ; C07D231/56 ; C07F7/08 ; C07D487/04 ; C07D417/04 ; C07D417/14 ; C07D471/04 ; C07D513/04 ; C07F9/6558
Abstract:
The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.
Public/Granted literature
- US20220098219A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME Public/Granted day:2022-03-31
Information query
IPC分类:
